ENVERIC BIOSCIENCES, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1f2ee781-2e8b-43f7-a4b7-40195c1f678b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $12.1M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-016543 |
| FY 2024 | $9.6M | 2024-01-01 – 2024-12-31 | evidence 0001493152-26-016543 |
| FY 2023 | $17.5M | 2023-01-01 – 2023-12-31 | evidence 0001493152-26-016543 |
| FY 2022 | $-18.5M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-010431 |
| FY 2021 | $-49.0M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008510 |
| FY 2020 | $-6.9M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-007757 |
| FY 2019 | $-2.4M | 2019-01-01 – 2019-12-31 | evidence 0001493152-21-007757 |
| FY 2018 | $-16.9M | 2018-01-01 – 2018-12-31 | evidence 0001140361-19-005573 |
| FY 2017 | $-9.1M | 2017-01-01 – 2017-12-31 | evidence 0001140361-18-016275 |
| FY 2016 | $-2.8M | 2016-01-01 – 2016-12-31 | evidence 0001079974-17-000131 |
| FY 2015 | $-814.1k | 2015-01-01 – 2015-12-31 | evidence 0001079974-17-000131 |
| FY 2014 | $423.3k | 2014-04-01 – 2015-03-31 | evidence 0001079974-16-001044 |
| FY 2013 | $414.6k | 2013-04-01 – 2014-03-31 | evidence 0001079974-16-001044 |
| FY 2012 | $-24.6k | 2012-01-01 – 2012-12-31 | evidence 0001477932-13-000935 |
| FY 2011 | $-33.4k | 2011-01-01 – 2011-12-31 | evidence 0001477932-12-000619 |
| FY 2010 | $-39.4k | 2010-01-01 – 2010-12-31 | evidence 0001477932-12-000619 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ENVERIC BIOSCIENCES, INC. — all facts · Revenue · Operating Income